Novel compounds demonstrate anticancer and antiviral properties, suggesting potential industrial applicability.
We synthesised novel compounds containing 6-chloro-3-isopropyl-1-methylpyrimidine-2,4(1H,3H)-dione without a catalyst. These molecules can potentially demonstrate exceptional anticancer, antiviral, and bactericidal properties while being safe for use. These compounds represent a minor modification of Mavacamten. Additionally, we can efficiently produce them on an industrial scale. They may also serve as active components in medicinal and veterinary antifungal agents.
No takes yet. Share an insight, caveat, or question.
Shingare et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: